Old Mission Capital’s Bioventus BVS Stock Holding History

Old Mission Capital’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-58,337	Closed	-$169K	–	1312
2023 Q2	$169K	Buy	+58,337	New	+$112K	﹤0.01%	1013

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Old Mission Capital's BVS Position: Q3 2023 in Review

Old Mission Capital sold out of Bioventus (BVS) in Q3 2023, closing a stake of 58,337 shares — an estimated $169K sold.

Old Mission Capital first reported a position in BVS in Q2 2023 and held it in 1 quarter. The position peaked at $169K in Q2 2023. 67 funds tracked by Wall St. Rank hold BVS as of Q3 2023.

Old Mission Capital reported no remaining Bioventus position as of Q3 2023 after selling out during the quarter.
Old Mission Capital sold 58,337 Bioventus shares in Q3 2023, an estimated $169K.
Old Mission Capital first reported a position in Bioventus in Q2 2023 and held it in 1 quarter.
Old Mission Capital's Bioventus position peaked at $169K in Q2 2023.
67 funds tracked by Wall St. Rank held Bioventus as of Q3 2023.

Based on Old Mission Capital's 13F filing for Q3 2023, filed 15 Nov 2023.